Haddis Hagos, MD
Pain Medicine · Greenbelt, MDNPI 1386613347
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,776 of the $7,538 with a category attached, or 76.6%. 35 manufacturers reported payments, led by Medtronic at 30.7% of the total.
Across 171 payments — averaging $44.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$1K
- Vertos Medical, Inc.$825
- Spinefrontier, Inc.$807
- Boston Scientific$381
- Nevro Corp.$195
- plus $2K from 29 others
What the payments were for
- Travel & lodging$1,74323%
- Food & beverage$5,77677%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 24 | $2,311 |
| Abbott | 49 | $1,248 |
| Vertos Medical, Inc. | 13 | $825 |
| Spinefrontier, Inc. | 3 | $807 |
| Boston Scientific | 13 | $381 |
| Nevro Corp. | 8 | $195 |
| Spinal Simplicity, LLC | 2 | $171 |
| Stryker | 2 | $168 |
| Si-bone, Inc. | 2 | $167 |
| Alnylam Pharmaceuticals Inc. | 9 | $161 |
| GRT US Holding, Inc. | 1 | $156 |
| Curonix LLC | 4 | $116 |
| Stimwave Technologies Incorporated | 3 | $105 |
| Globus Medical | 4 | $96 |
| Redhill Biopharma Inc. | 4 | $87 |
| Scilex Pharmaceuticals Inc. | 4 | $71 |
| Almatica Pharma LLC | 4 | $59 |
| Bioventus LLC | 2 | $54 |
| IBSA Pharma Inc. | 2 | $41 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Fidia Pharma USA Inc. | 1 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Vertex | 1 | $24 |
| Biotronik NRO, Inc. | 1 | $24 |
| Relievant Medsystems, Inc. | 1 | $21 |
| Painteq LLC | 1 | $21 |
| MDD US Operations, LLC | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| Valinor Pharma, LLC | 1 | $17 |
| Saluda Medical Americas, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
| Foundation Fusion Solutions, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$1,054
- InSpan$807
- SIJFuse$807
- FacetFuse$807
- NanoFuse$807
- mild Device Kit$801
- INCEPTIV$350
- PROCLAIM$336
- SPECTRA WAVEWRITER$159
- Qutenza$156
- iFuse Implant$150
- HA MINUTEMAN G3-R$145
- INTELLIS ADAPTIVESTIM$130
How this compares
$7,538 in reported general payments places this provider in the 75th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 452 | $9,219 |
| MovantikNaloxegol Oxalate | 15 | $7,427 |
| OxycontinOxycodone Hcl | 18 | $6,404 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $5,020 |
| Lidocaine | 22 | $4,762 |
| Oxycodone Hcl | 131 | $2,193 |
| Gabapentin | 158 | $2,014 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $1,792 |
| Pregabalin | 47 | $1,728 |
| Diclofenac Sodium | 32 | $1,219 |
| Fentanyl | 15 | $942 |
| Duloxetine Hcl | 81 | $929 |
| Methadone Hcl | 99 | $896 |
| Buprenorphine Hcl | 22 | $833 |
| Cyclobenzaprine Hcl | 88 | $788 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $87 | $7,42715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 144 pain medicine providers in Maryland.
Other pain medicine in Greenbelt
- Reza GhorbaniGreenbelt$24K
- Netsere TesfayohannesGreenbelt$5K
- Vipul MangalOxon Hill$764K
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Kunal SoodGermantown$70K
- Ali TurabiBethesda$47K
- Behnam JafarpourBaltimore$45K
- Eric FinkelsteinOwings Mills$37K
- Ankush JainBethesda$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.